Co-Targeting CD38 with a Chimeric Costimulatory Receptor Enhances Adoptive T Cell Therapy for Hematological Malignancies

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)40-41
JournalMolecular Therapy
Volume28
Issue number4
Publication statusPublished - 28 Apr 2020

Cite this